Why we need to save our skins - Independent

While it is welcome news for cancer patients that the drug Ipilimumab has been approved for the treatment of Irish patients with malignant melanoma (Irish Independent, May 4), we need to take a lead from our Northern neighbours if we want to be truly ...

New therapeutic options for management of melanoma brain metastases - News-Medical.Net

The effect on brain metastases of drugs such as Dabrafenib, Vemurafenib and Ipilimumab - which do not normally cross the blood-brain barrier - is likely reflective of a breakdown in the integrity of the blood-brain barrier as tumors grow ...

Ireland's Eye: What's going on in the old sod this week - Irish Central

The Ashbourne father who last week made a desperate plea for the life-saving cancer drug Ipilimumab (Ipy) had his wish granted when Taoiseach (Prime Minister) Enda Kenny announced last Thursday that the drug would be made available to cancer ...

Immunotherapy Drugs: Two Drugs Harness Immune System To Fight Cancer - Huffington Post

"We've proposed a new set of response criteria to try to incorporate some of this biology." Yervoy, or ipilimumab, became the first drug ever to extend survival in patients with advanced melanoma, long seen as a short-term death sentence.

Melanoma Agent Surprise: Brain Tumors Shrink Too - Medscape News

Gibney and Sondak. Some systemic therapies for melanoma, including ipilimumab, have demonstrated a positive but limited impact on brain metastases, as reported by Medscape Medical News. "Clearly, systemic agents of increased effectiveness are needed for ...

Vical's CEO Presents at Bank of America Merrill Lynch Health Care Conference Call (Transcript) - Seekingalpha.com

So that should move that number 22.5 months further north. And then we’ve shown at least in animal models that CTLA ipilimumab synergies with Allovectin-7 that should further impact that number. So the number could be greater than 22.5 months.

Lung Cancer: New Drugs, Emerging Therapies - Medscape News

Trials of ipilimumab are ongoing as well, but the PD1 data are going to be important. One last thing that all medical oncologists who treat lung cancer patients should look at is an abstract by Rudy Navari [5] in the supportive care section.

Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019 - new market research report - Transworld News

The current treatment options for melanoma include: - Newly approved targeted therapies such as Yervoy(ipilimumab) and Zelboraf(vemurafenib) - Adjuvant therapies such as Intron-A (interferon alfa-2b) and Sylatron(peg-interferon alfa-2b) - Immunotherapy ...

BioTrends tracks uptake of Yervoy and Zelboraf for advanced melanoma - News-Medical.Net

BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, has released findings from the second wave of its LaunchTrends ® Yervoy and Zelboraf report, in which 103 U.S.-based ...